Suppr超能文献

局部晚期非小细胞肺癌的放射治疗时间与总生存期

Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.

作者信息

McMillan Matthew T, Ojerholm Eric, Verma Vivek, Higgins Kristin A, Singhal Sunil, Predina Jarrod D, Berman Abigail T, Grover Surbhi, Robinson Cliff G, Simone Charles B

机构信息

Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska.

出版信息

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1142-1152. doi: 10.1016/j.ijrobp.2017.04.004. Epub 2017 Apr 11.

Abstract

PURPOSE

Prolonged radiation treatment (RT) time (RTT) has been associated with worse survival in several malignancies. The present study investigated whether delays during RT are associated with overall survival (OS) in non-small cell lung cancer (NSCLC).

METHODS AND MATERIALS

The National Cancer Database was queried for patients with stage III NSCLC who had received definitive concurrent chemotherapy and fractionated RT to standard doses (59.4-70.0 Gy) and fractionation from 2004 to 2013. The RTT was classified as standard or prolonged for each treatment regimen according to the radiation dose and number of fractions. Cox proportional hazards models were used to evaluate the association between the following factors and OS: RTT, RT fractionation, demographic and pathologic factors, and chemotherapeutic agents.

RESULTS

Of 14,154 patients, the RTT was prolonged in 6262 (44.2%). Factors associated with prolonged RTT included female sex (odds ratio [OR] 1.21, P<.0001), black race (OR 1.20, P=.001), nonprivate health insurance (OR 1.30, P<.0001), and lower income (<$63,000 annually, OR 1.20, P<.0001). The median OS was significantly worse for patients with prolonged RTT than that for those with standard RTT (18.6 vs 22.7 months, P<.0001). Furthermore, the OS worsened with each cumulative interval of delay (standard RTT vs prolonged 1-2 days, 20.5 months, P=.009; prolonged 3-5 days, 17.9 months, P<.0001; prolonged 6-9 days, 17.7 months, P<.0001; prolonged >9 days, 17.1 months, P<.0001). On multivariable analysis, prolonged RTT was independently associated with inferior OS (hazard ratio 1.21, P<.0001). Prolonged RTT as a continuous variable was also significantly associated with worse OS (hazard ratio 1.001, P=.0007).

CONCLUSIONS

Delays during RT appear to negatively affect survival for patients with locally advanced NSCLC. We have detailed the demographic and socioeconomic barriers influencing prolonged RTT as a method to address the health disparities in this regard. Cumulative interruptions of RT should be minimized.

摘要

目的

在多种恶性肿瘤中,延长放疗时间(RTT)与较差的生存率相关。本研究调查了非小细胞肺癌(NSCLC)放疗期间的延迟是否与总生存期(OS)相关。

方法和材料

查询国家癌症数据库中2004年至2013年接受确定性同步化疗和标准剂量(59.4 - 70.0 Gy)分次放疗的III期NSCLC患者。根据放疗剂量和分次次数,将每个治疗方案的RTT分类为标准或延长。使用Cox比例风险模型评估以下因素与OS之间的关联:RTT、放疗分次、人口统计学和病理因素以及化疗药物。

结果

在14154例患者中,6262例(44.2%)的RTT延长。与RTT延长相关的因素包括女性(比值比[OR] 1.21,P <.0001)、黑人种族(OR 1.20,P =.001)、非私人医疗保险(OR 1.30,P <.0001)和低收入(每年<$63000,OR 1.20,P <.0001)。RTT延长的患者的中位OS明显差于RTT标准的患者(18.6个月对22.7个月,P <.0001)。此外,随着延迟的每个累积间隔,OS恶化(标准RTT对延长1 - 2天,20.5个月,P =.009;延长3 - 5天,17.9个月,P <.0001;延长6 - 9天,17.7个月,P <.0001;延长>9天,17.1个月,P <.0001)。在多变量分析中,延长的RTT与较差的OS独立相关(风险比1.21,P <.0001)。RTT作为连续变量延长也与较差的OS显著相关(风险比1.001,P =.0007)。

结论

放疗期间的延迟似乎对局部晚期NSCLC患者的生存有负面影响。我们详细阐述了影响RTT延长的人口统计学和社会经济障碍,作为解决这方面健康差异的一种方法。应尽量减少放疗的累积中断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验